C Richon

Learn More
BACKGROUND Combination of age at diagnosis, stage and MYCN amplification stratifies neuroblastoma into low-risk and high-risk. We aimed to establish whether a microRNA (miRNA) signature could be associated with prognosis in both groups. METHODS Microarray expression profiling of human miRNAs and quantitative reverse-transcriptase PCR of selected miRNAs(More)
  • 1